New 52 Week Low Today

SAGE Therapeutics Inc SAGE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/15/24 EDT
15.29quote price arrow down-0.03 (-0.20%)
Volume
25,735
Close
15.32UNCH (UNCH)
Volume
820,036
52 week range
15.06 - 59.99
Loading...
  • Open15.60
  • Day High15.60
  • Day Low15.06
  • Prev Close15.32
  • 52 Week High59.99
  • 52 Week High Date06/12/23
  • 52 Week Low15.06
  • 52 Week Low Date04/15/24

Key Stats

  • Market Cap920.834M
  • Shares Out60.11M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change-29.3

KEY STATS

  • Open15.60
  • Day High15.60
  • Day Low15.06
  • Prev Close15.32
  • 52 Week High59.99
  • 52 Week High Date06/12/23
  • 52 Week Low15.06
  • 52 Week Low Date04/15/24
  • Market Cap920.834M
  • Shares Out60.11M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change-29.3

RATIOS/PROFITABILITY

  • EPS (TTM)-9.05
  • P/E (TTM)-1.69
  • Fwd P/E (NTM)-2.40
  • EBITDA (TTM)-545.071M
  • ROE (TTM)-52.77%
  • Revenue (TTM)86.456M
  • Gross Margin (TTM)97.50%
  • Net Margin (TTM)-626.32%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/25/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SAGE Therapeutics Inc

 

Profile

MORE
Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a...
Geno Germano
Independent Chairman of the Board
Barry Greene
President, Chief Executive Officer, Director
Kimi Iguchi
Chief Financial Officer, Treasurer
Address
215 1st St
Cambridge, MA
02142-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
RGNX
Regenxbio Inc
18.02UNCHUNCH
IMTX
Immatics NV
10.40UNCHUNCH
VIR
Vir Biotechnology Inc
8.57UNCHUNCH
MGNX
MacroGenics Inc
16.94UNCHUNCH
PRTA
Prothena Corporation PLC
21.99UNCHUNCH